BIO
BIO
NYSE · Life Sciences Tools & Services

Bio-Rad Laboratories-A

$272.12
+7.12 (+2.69%)
As of Mar 24, 9:47 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.55B
Net Income
749.43M
Gross Margin
52.0%
Profit Margin
29.4%
Rev Growth
-2.7%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.0% 52.0% 34.0% 34.0%
Operating Margin 1.6% 1.4% 7.9% 9.4%
Profit Margin 29.4% 28.0% 8.4% 9.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.55B 2.62B 3.74B 3.63B
Gross Profit 1.33B 1.36B 1.27B 1.24B
Operating Income 40.51M 37.46M 295.48M 340.82M
Net Income 749.43M 693.06M 316.01M 332.31M
Gross Margin 52.0% 52.0% 34.0% 34.0%
Operating Margin 1.6% 1.4% 7.9% 9.4%
Profit Margin 29.4% 28.0% 8.4% 9.2%
Rev Growth -2.7% -2.7% +9.0% +2.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 494.46M 494.46M 3.59B 2.84B
Total Equity 3.06B 3.06B 4.06B 4.19B
D/E Ratio 0.16 0.16 0.89 0.68
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 40.44M 39.47M 492.25M 510.81M
Free Cash Flow 138.31M 190.89M